Site US00002 — New York, New York

Site US00002 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US00002 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Urothelial Cancer and Other Malignant Solid Tumors.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00002?

Site US00002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00002 conducted?

Site US00002 has 1 clinical trials on record. Their work covers Metastatic Urothelial Cancer and Other Malignant Solid Tumors.

Is Site US00002 accredited by Crixeo Health?

Site US00002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.